Evidence map›Paper›PMID 22308251›Full record

Trial reportStroke2012

Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.

Jeffrey S Berger, Aileen P McGinn, Barbara V Howard, Lewis Kuller, Joann E Manson, Jim Otvos, J David Curb, Charles B Eaton, Robert C Kaplan, John K Lynch and 2 more

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Stroke, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The associations of lipids and lipid ratios with stroke: A prospective cohort study.Journal of clinical hypertension (Greenwich, Conn.) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Jeffrey S BergerFAHA, New York University School of Medicine, 530 First Ave, Skirball 9R, New York, NY 10016, USA. jeffrey.berger@nyumc.org
Aileen P McGinn
Barbara V Howard
Lewis Kuller
Joann E Manson
Jim Otvos
J David Curb
Charles B Eaton
Robert C Kaplan
John K Lynch
Daniel M Rosenbaum
Sylvia Wassertheil-Smoller
Georgetown University · USUniversity of Hawaiʻi at Mānoa · USUniversity of Pittsburgh · USHarvard University · USMedStar Georgetown University Hospital · USMemorial Hospital of Rhode Island · USNational Institute of Neurological Disorders and Stroke · USNew York University · US

Funding

Hormones and Biomarkers Predicting Stroke in WomenR01NS042618 · NINDS · YESHIVA UNIVERSITY · PI WASSERTHEIL-SMOLLER, SYLVIA · 2003 to 2005
$1.8M
WOMENS HEALTH INITIATIVE-N01WH22110N01WH022110 · WH · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ROSS, PRENTICE · 1992 to 2006
$1.2M
NHLBI NIH HHS HHSN268201100046CNINDS NIH HHS R01 NS042618WHI NIH HHS N01 WH022110
6 · The paper itself

Abstract

backgroundFew studies simultaneously investigated lipids and lipoprotein biomarkers as predictors of ischemic stroke. The value of these biomarkers as independent predictors of ischemic stroke remains controversial.

methodsWe conducted a prospective nested case-control study among postmenopausal women from the Women's Health Initiative Observational Study to assess the relationship between fasting lipids (total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides), lipoproteins (LDL, HDL, and very low-density lipoprotein [VLDL] particle number and size, intermediate-density lipoprotein [IDL] particle number, and lipoprotein (a)), and risk of ischemic stroke. Among women free of stroke at baseline, 774 ischemic stroke patients were matched according to age and race to control subjects, using a 1:1 ratio.

resultsIn bivariate analysis, baseline triglycerides (P<0.001), IDL particles (P<0.01), LDL particles (P<0.01), VLDL triglyceride (P<0.001), VLDL particles (P<0.01), VLDL size (P<0.001), LDL size (P=0.03), and total/HDL cholesterol ratio (P<0.01) were significantly higher among women with incident ischemic stroke, whereas levels of HDL-C (P<0.01) and HDL size (P<0.01) were lower. No significant baseline difference for total cholesterol (P=0.15), LDL-C (P=0.47), and lipoprotein (a) (P=0.11) was observed. In multivariable analysis, triglycerides (odds ratio for the highest versus lowest quartile, 1.56; 95% confidence interval, 1.13-2.17; P for trend=0.02), VLDL size (odds ratio, 1.59; 95% confidence interval, 1.10-2.28; P for trend=0.03), and IDL particle number (odds ratio, 1.46; 95% confidence interval, 1.04-2.04; P for trend=0.02) were significantly associated with ischemic stroke.

conclusionsAmong a panel of lipid and lipoprotein biomarkers, baseline triglycerides, VLDL size, and IDL particle number were significantly associated with incident ischemic stroke in postmenopausal women.

Indexed as

AgedBiomarkersBrain IschemiaCase-Control StudiesCholesterolFemaleHumansIncidenceLipoproteinsPostmenopauseProspective StudiesRisk FactorsStrokeBiomarkersCholesterolLipoproteins

Identifiers

PMID22308251
PMCPMC3547588
OpenAlexW2150587632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.